These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 12894225)

  • 21. Regulation of hairy-cell survival through constitutive activation of mitogen-activated protein kinase pathways.
    Kamiguti AS; Harris RJ; Slupsky JR; Baker PK; Cawley JC; Zuzel M
    Oncogene; 2003 Apr; 22(15):2272-84. PubMed ID: 12700663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of GDF-8 signaling by the p38 MAPK.
    Philip B; Lu Z; Gao Y
    Cell Signal; 2005 Mar; 17(3):365-75. PubMed ID: 15567067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A mechanism of repression of TGFbeta/ Smad signaling by oncogenic Ras.
    Kretzschmar M; Doody J; Timokhina I; Massagué J
    Genes Dev; 1999 Apr; 13(7):804-16. PubMed ID: 10197981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Smad3 mediates transforming growth factor-beta-induced collagenase-3 (matrix metalloproteinase-13) expression in human gingival fibroblasts. Evidence for cross-talk between Smad3 and p38 signaling pathways.
    Leivonen SK; Chantry A; Hakkinen L; Han J; Kahari VM
    J Biol Chem; 2002 Nov; 277(48):46338-46. PubMed ID: 12270924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interdependent SMAD and JNK signaling in transforming growth factor-beta-mediated transcription.
    Engel ME; McDonnell MA; Law BK; Moses HL
    J Biol Chem; 1999 Dec; 274(52):37413-20. PubMed ID: 10601313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p38 mitogen-activated protein kinase functionally contributes to chondrogenesis induced by growth/differentiation factor-5 in ATDC5 cells.
    Nakamura K; Shirai T; Morishita S; Uchida S; Saeki-Miura K; Makishima F
    Exp Cell Res; 1999 Aug; 250(2):351-63. PubMed ID: 10413589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genistein inhibits matrix metalloproteinase type 2 activation and prostate cancer cell invasion by blocking the transforming growth factor beta-mediated activation of mitogen-activated protein kinase-activated protein kinase 2-27-kDa heat shock protein pathway.
    Xu L; Bergan RC
    Mol Pharmacol; 2006 Sep; 70(3):869-77. PubMed ID: 16772519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin 1 β-induced SMAD2/3 linker modifications are TAK1 dependent and delay TGFβ signaling in primary human mesenchymal stem cells.
    van den Akker GG; van Beuningen HM; Vitters EL; Koenders MI; van de Loo FA; van Lent PL; Blaney Davidson EN; van der Kraan PM
    Cell Signal; 2017 Dec; 40():190-199. PubMed ID: 28943409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interfering with TGFbeta-induced Smad3 nuclear accumulation differentially affects TGFbeta-dependent gene expression.
    Lindemann RK; Nordheim A; Dittmer J
    Mol Cancer; 2003 Mar; 2():20. PubMed ID: 12747808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p38 mitogen-activated protein kinase is required for TGFbeta-mediated fibroblastic transdifferentiation and cell migration.
    Bakin AV; Rinehart C; Tomlinson AK; Arteaga CL
    J Cell Sci; 2002 Aug; 115(Pt 15):3193-206. PubMed ID: 12118074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TGF-beta1 (transforming growth factor-beta1)-mediated adhesion of gastric carcinoma cells involves a decrease in Ras/ERKs (extracellular-signal-regulated kinases) cascade activity dependent on c-Src activity.
    Kim HP; Lee MS; Yu J; Park JA; Jong HS; Kim TY; Lee JW; Bang YJ
    Biochem J; 2004 Apr; 379(Pt 1):141-50. PubMed ID: 14720123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of the Erk mitogen-activated protein kinase pathway stimulates neuroendocrine differentiation in LNCaP cells independently of cell cycle withdrawal and STAT3 phosphorylation.
    Kim J; Adam RM; Freeman MR
    Cancer Res; 2002 Mar; 62(5):1549-54. PubMed ID: 11888934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of the antiproliferative effect of TGFbeta by EGF in primary human ovarian cancer cells.
    Dunfield LD; Nachtigal MW
    Oncogene; 2003 Jul; 22(30):4745-51. PubMed ID: 12879019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Divergence of epidermal growth factor - transforming growth factor beta signaling in embryonic orofacial tissue.
    Bhattacherjee V; Greene RM; Michele Pisano M
    In Vitro Cell Dev Biol Anim; 2003; 39(5-6):257-61. PubMed ID: 12880367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p38 mitogen-activated protein kinase and alkaline phosphatase in human dental pulp cells.
    Wang FM; Hu T; Zhou X
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Jul; 102(1):114-8. PubMed ID: 16831683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The antifibrotic effects of relaxin in human renal fibroblasts are mediated in part by inhibition of the Smad2 pathway.
    Heeg MH; Koziolek MJ; Vasko R; Schaefer L; Sharma K; Müller GA; Strutz F
    Kidney Int; 2005 Jul; 68(1):96-109. PubMed ID: 15954899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intracellular dynamics of Smad-mediated TGFbeta signaling.
    Greene RM; Nugent P; Mukhopadhyay P; Warner DR; Pisano MM
    J Cell Physiol; 2003 Nov; 197(2):261-71. PubMed ID: 14502566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sorting nexin 9 differentiates ligand-activated Smad3 from Smad2 for nuclear import and transforming growth factor β signaling.
    Wilkes MC; Repellin CE; Kang JH; Andrianifahanana M; Yin X; Leof EB
    Mol Biol Cell; 2015 Nov; 26(21):3879-91. PubMed ID: 26337383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growth hormone- and prolactin-induced proliferation of insulinoma cells, INS-1, depends on activation of STAT5 (signal transducer and activator of transcription 5).
    Friedrichsen BN; Galsgaard ED; Nielsen JH; Møldrup A
    Mol Endocrinol; 2001 Jan; 15(1):136-48. PubMed ID: 11145745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TGF-beta-induced nuclear localization of Smad2 and Smad3 in Smad4 null cancer cell lines.
    Fink SP; Mikkola D; Willson JK; Markowitz S
    Oncogene; 2003 Mar; 22(9):1317-23. PubMed ID: 12618756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.